Table 2 |
||||
|
Fatty acids from the isolated plasma phospholipids described as means ± SD and median.* |
||||
| Plasma FA |
Baseline |
Week 4 |
Week 8 |
|
|
|
||||
| n-6 |
||||
| 18:2 (LA) |
22.61 ± 1.39 |
17.81 ± 2.85 |
21.88 ± 4.89 |
|
| median |
21.95 |
17.49 |
21.08 |
|
| 20:3 (DGLA) |
3.12 ± 0.44 |
1.86 ± 0.82 |
2.15 ± 0.64 |
|
| median |
3.09 |
2.25 |
2.05 |
|
| 20:4 (AA) |
9.52 ± 0.70 |
8.92 ± 0.83 |
8.69 ± 1.30 |
|
| median |
9.34 |
8.92 |
8.37 |
|
| n-3 |
||||
| 18:3 (LNA) |
0.13 ± 0.07 |
0.13 ± 0.07 |
0.13 ± 0.06 |
|
| median |
0.13 |
0.1 |
0.12 |
|
| 20:5 (EPA) |
0.49 ± 0.12 |
5.89 ± 4.27a |
4.64 ± 3.65a |
|
| median |
0.46 |
6.13 |
4.72 |
|
| 22:6 (DHA) |
2.30 ± 0.88 |
5.68 ± 1.28a |
5.61 ± 2.14a |
|
| median |
2.07 |
6.11 |
6.19 |
|
| Totals and ratios |
||||
| Saturated |
44.29 ± 0.99 |
43.94 ± 1.26 |
42.19 ± 1.05 |
|
| median |
44.2 |
44.04 |
42.53 |
|
| Monounsaturated |
15.43 ± 1.38 |
13.64 ± 1.18 |
12.31 ± 2.12 |
|
| median |
15.7 |
13.51 |
11.93 |
|
| Polyunsaturated |
40.27 ± 1.03 |
42.41 ± 1.43 |
45.51 ± 1.26 |
|
| median |
40.21 |
42.02 |
45.38 |
|
| total n-6 |
36.37 ± 0.99 |
29.07 ± 4.31a |
33.42 ± 5.67 |
|
| median |
36.57 |
29.54 |
31.59 |
|
| total n-3 |
3.90 ± 0.87 |
13.35 ± 5.27a |
12.09 ± 6.17a |
|
| median |
3.66 |
12.74 |
13.38 |
|
| n-6: n-3 ratio |
9.74 ± 2.14 |
2.79 ± 1.88a |
3.93 ± 2.73a |
|
| median |
9.61 |
2.39 |
2.36 |
|
| AA:EPA ratio |
20.78 ± 5.26 |
4.19 ± 5.45a |
5.95 ± 7.35a |
|
| median |
20.14 |
1.46 |
1.69 |
|
| AA:EPA ratio (n = 7)# |
20.73 ± 5.26 |
2.53 ± 3.49a |
2.52 ± 2.91 |
|
| median |
19.58 |
1.34 |
1.39 |
|
|
|
||||
|
* Values are mean ± SD and medians (n = 9). a p < 0.01 using Wilcoxon signed rank test to compare to baseline. LA, linoleic acid; DGLA, dihomogammalinolenic acid; AA, arachidonic acid; LNA, linolenic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. |
||||
|
Sorgi et al. Nutrition Journal 2007 6:16 doi:10.1186/1475-2891-6-16 |
||||
